HuagongsheHuagongshe Chemistry Print Report · For research reference only
(3,5-Dimethylpyrazin-2-yl)piperazine hydrochloride → [(3,5-Dimethylpyrazin-2-yl)piperazin-4-yl] {4-[1-(1,1-dioxo-1lambda6-isothiazolidin-2-yl)-1-methylethyl]phenyl}methanone
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (3,5-Dimethylpyrazin-2-yl)piperazine hydrochloride | HCID 67381341 | — |
| Reactant | HCID 71251965 | HCID 71251965 | — |
| Product | [(3,5-Dimethylpyrazin-2-yl)piperazin-4-yl] {4-[1-(1,1-dioxo-1lambda6-isothiazolidin-2-yl)-1-methylethyl]phenyl}methanone | HCID 71261332 | 53.9% |
Reaction Steps
Using 4-[1-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-1-methylethyl]benzoic acid (100 mg) described in Preparation Example 39 and (3,5-dimethylpyrazin-2-yl)piperazine hydrochloride (81 mg) described in Preparation Example 104 and by the reaction and treatment in the same manner as in Example 86, the title compound (87 mg) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08816079B2 |
| Source dataset | uspto-grants-2014_08 |
| ORD ID | ord-aa9f44ac23fd4d13920cd0b68fe63d6c |
| Source note | uspto-grants-2014_08 |